BPC 157 FDA approval status 2026: Is it legal? Veedma The FDA Didnt Green Light Peptides Heres What Actually Happened BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from Know your risk factors